#biasinai
FDA issues 2025 AI guidance for medical software with focus on lifecycle, bias, and security
On January 7, 2025, the United States Food and Drug Administration (FDA) released a significant draft guidance titled “Artificial Intelligence and Machine Learning in Software as a Medical Device.” While the release may not have received widespread media attention, its impact on startups and innovators in the healthcare technology space is expected to be profound. The document outlines new expectations for how companies should design, test, validate, and monitor AI-powered medical
FDA issues 2025 AI guidance for medical software with focus on lifecycle, bias, and security
On January 7, 2025, the United States Food and Drug Administration (FDA) released a significant draft guidance titled “Artificial Intelligence and Machine Learning in Software as a Medical Device.” While the release may not have received widespread media attention, its impact on startups and innovators in the healthcare technology space is expected to be profound. The document outlines new expectations for how companies should design, test, validate, and monitor AI-powered medical









